March 08, 2023 The ink dries on the blank cheque craze As Apexigen throws in the towel six months after listing, can any bright spots be found in the stats on Spacs?
October 12, 2022 Kinnate is the latest Raf player to trip up The company’s attempt to segment Braf-mutant cancers further isn’t going smoothly.
